Tatsuya Toyama

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy

Joji Kato, Yoshiyuki Kuwabara, Masami Mitani et al. · International Journal of Cancer · 2001 · 331 citations

Medicine, Cancer Biology, Oncology +11

Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*

Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama et al. · Breast Cancer Research and Treatment · 2005 · 306 citations

Life Sciences, Molecular Biology, Oncology +9

miR-206 Expression Is Down-regulated in Estrogen Receptor α–Positive Human Breast Cancer

Naoto Kondo, Tatsuya Toyama, Hiroshi Sugiura et al. · Cancer Research · 2008 · 302 citations · Full text

Medicine, Molecular Biology, Oncology +13

HDAC6 Expression Is Correlated with Better Survival in Breast Cancer

Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama et al. · Clinical Cancer Research · 2004 · 296 citations · Full text

Life Sciences, Molecular Biology, Oncology +17